Accelerometry-based physical activity and exercise capacity in pediatric kidney transplant patients.

Background: Low physical activity (PA) is increasingly recognized as a risk factor for children with chronic conditions. A few published studies have measured the exercise capacity of solid organ transplant patients; however, no studies have examined the PA intensity of pediatric kidney transplant patients (PTx) using accelerometry. Therefore, our objective was to complement a gold standard exercise capacity protocol with an objective measure to quantify PA intensity levels of PTx.

Physical activity and health related quality of life in children following kidney transplantation.

Participation in PA is often diminished in children with CKD. Limited research exists on exercise tolerance/capacity but no studies to date have investigated lifestyle PA and its determinants in these children. The aim of this study was to investigate level of PA and potential physiological and psychological associations in a group of pediatric KTx recipients compared with CS.

Exercise treatment for depression: efficacy and dose response.

Background: This study, conducted between 1998 and 2001 and analyzed in 2002 and 2003, was designed to test (1) whether exercise is an efficacious treatment for mild to moderate major depressive disorder (MDD), and (2) the dose-response relation of exercise and reduction in depressive symptoms.

Design: The study was a randomized 2x2 factorial design, plus placebo control.

Setting/participants: All exercise was performed in a supervised laboratory setting with adults (n =80) aged 20 to 45 years diagnosed with mild to moderate MDD.

The DOSE study: a clinical trial to examine efficacy and dose response of exercise as treatment for depression.

The Depression Outcomes Study of Exercise (DOSE) was a randomized clinical trial to determine whether exercise is an efficacious treatment for mild to moderate major depressive disorder (MDD) in adults ages 20 to 45 years. The specific hypotheses under investigation were (1) active exercise is an efficacious monotherapy for mild to moderate levels of MDD, and (2) there is a dose-response relation between the exercise amount and reduction in depressive symptoms. The primary outcome measure was the Hamilton Rating Scale for Depression (HRSD) collected weekly over 12 weeks.